[Regulation mechanism for rig-g gene expression induced by all-trans retinoic acid]. 2010

Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

To investigate the molecular mechanisms of all-trans retinoic acid (ATRA)-induced rig-g gene expression and to better understand the signal transduction of ATRA during acute promyelocytic leukemia (APL) cell differentiation, the luciferase reporter assay, co-immunoprecipitation and chromatin immunoprecipitation were used to clarify the basic transcriptional factors, which directly initiated the expression of rig-g gene. The results showed that the expression of STAT2, IRF-9 and IRF-1 could be upregulated by ATRA with different kinetics in NB4 cells. IRF-9 was able to interact with STAT2 to form a complex, which could bind the rig-g gene promoter and trigger the rig-g expression. IRF-1 alone could also activate the reporter gene containing rig-g gene promoter, but C/EBPalpha could strongly inhibit this transcription activity of IRF-1. It is concluded that during ATRA-induced APL cell differentiation, IRF-1 is first upregulated by ATRA, and then IRF-1 increases the protein levels of IRF-9 and STAT2 with the downregulation of C/EBPalpha. The complex of IRF-9 and STAT2 is the primary transcriptional factor for rig-g gene induction. This study will be helpful for better understanding the signal transduction networks of ATRA during the course of APL cell differentiation.

UI MeSH Term Description Entries
D005809 Genes, Regulator Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions. Gene, Regulator,Regulator Gene,Regulator Genes,Regulatory Genes,Gene, Regulatory,Genes, Regulatory,Regulatory Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias
D015973 Gene Expression Regulation, Leukemic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia. Leukemic Gene Expression Regulation,Regulation of Gene Expression, Leukemic,Regulation, Gene Expression, Leukemic
D047908 Intracellular Signaling Peptides and Proteins Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors. Intracellular Signaling Peptides,Intracellular Signaling Proteins,Peptides, Intracellular Signaling,Proteins, Intracellular Signaling,Signaling Peptides, Intracellular,Signaling Proteins, Intracellular
D050795 STAT2 Transcription Factor A signal transducer and activator of transcription that mediates cellular responses to TYPE I INTERFERONS. Stat2 protein is associated constitutively with INTERFERON REGULATORY FACTOR-9. After PHOSPHORYLATION Stat2 forms the IFN-STIMULATED GENE FACTOR 3 COMPLEX to regulate expression of target GENES. STAT2 Protein,Signal Transducer and Activator of Transcription 2,Transcription Factor STAT2,Factor STAT2, Transcription,Transcription Factor, STAT2
D050834 Interferon-Stimulated Gene Factor 3, gamma Subunit An interferon regulatory factor that recruits STAT1 PROTEIN and STAT2 PROTEIN heterodimers to interferon-stimulated response elements and functions as an immediate-early protein. ISGF3 gamma Subunit,ISGF3G Protein,ISRE-Binding Protein p48,Interferon Regulatory Factor-9,p48 ISGF3gamma,p48 ISRE-Binding Protein,ISGF3gamma, p48,ISRE Binding Protein p48,ISRE-Binding Protein, p48,Interferon Regulatory Factor 9,Interferon Stimulated Gene Factor 3, gamma Subunit,Regulatory Factor-9, Interferon,p48 ISRE Binding Protein,p48, ISRE-Binding Protein

Related Publications

Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
May 1995, Biochemical and biophysical research communications,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
July 1996, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
May 2009, The FEBS journal,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
January 2013, PloS one,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
May 2002, American journal of hematology,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
January 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
December 2005, British journal of haematology,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
May 2004, Journal of cellular biochemistry,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
September 2001, Anti-cancer drugs,
Xiao-Rong Pan, and Ye-Jiang Lou, and Zhang-Lin Zhang, and Gui-Ping Xu, and Pei-Min Jia, and Jian-Hua Tong
April 1994, Journal of the National Cancer Institute,
Copied contents to your clipboard!